Li-Ting Cheng
7PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 18, 2026
Enhancing the immunogenicity of a recombinant PEDV subunit vaccine: the role of lipoprotein signal peptide.Haroon Afzal, Muhammad Umar, Nguyen-Thanh Hoa
|Jan 24, 2025
Lipoprotein Signal Peptide as Adjuvants: Leveraging Lipobox-Driven TLR2 Activation in Modern Vaccine Design.Muhammad Umar, Haroon Afzal, Asad Murtaza
|Feb 24, 2024
Advancing PEDV Vaccination: Comparison between Inactivated and Flagellin N-Terminus-Adjuvanted Subunit Vaccines.Asad Murtaza, Nguyen-Thanh Hoa, Do Dieu-Huong
|Nov 11, 2022
Flagellin Improves the Immune Response of an Infectious Bursal Disease Virus (IBDV) Subunit Vaccine.Asad Murtaza, Haroon Afzal, Thu-Dung Doan
|May 28, 2022
Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling.Chao-Hung Chen, Yu-Jen Lin, Li-Ting Cheng
|Apr 23, 2022
Development of a Subunit Vaccine against Duck Hepatitis A Virus Serotype 3.Trang-Nhu Truong, Li-Ting Cheng
Pageof 2
